RecruitingPhase 2NCT07304089

A Study to Evaluate the Efficacy, Safety, and Tolerability of VIM0423 in Individuals With Isolated Dystonia

Studying Focal, segmental or multifocal dystonia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Vima Therapeutics
Intervention
VIM0423(drug)
Enrollment
100 enrolled
Eligibility
18-65 years · All sexes
Timeline
20262027

Study locations (30)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07304089 on ClinicalTrials.gov

Other trials for Focal, segmental or multifocal dystonia

Additional recruiting or active studies for the same condition.

See all trials for Focal, segmental or multifocal dystonia

← Back to all trials